123 See
123 See is a startup headquartered in Boston, United States, founded in 2021. It has raised at least $30.3m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
123 See has raised at least $30.3m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
123 See sits inside the Boston and New England R&D ecosystem in the Global R&D Labs Directory.
Other startups in Boston
- 7AI
- Acta Pharmaceuticals
- Acumino
- AdvocateMH
- AI Proteins
- Amplitude Vascular Systems
- Animerra
- Anna Health
- Antares Therapeutics
- Appex Group
- Atalan Tech
Related
- Innovation profile of Boston
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does 123 See do?
123 See is classed in technology in its filings with the US Securities and Exchange Commission.
How much has 123 See raised?
At least $30.3m, according to its Form D filings with the US Securities and Exchange Commission.
Where is 123 See based?
123 See is headquartered in Boston, United States.
When was 123 See founded?
123 See was founded in 2021.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.